Masaki Katayama

Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High‐Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti–Melanoma Differentiation–Associated Gene 5–Positive Dermatomyositis

Hideaki Tsuji, Ran Nakashima, Yuji Hosono et al. · Arthritis & Rheumatology · 2019 · 344 citations · Full text

The inhibitory effects of mangiferin, a naturally occurring glucosylxanthone, in bowel carcinogenesis of male F344 rats

Naoki Yoshimi, Kengo Matsunaga, Masaki Katayama et al. · Cancer Letters · 2001 · 213 citations

Inhibitory Effects, Chemoprevention Strategy, Male F344 Rats +6

Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study-

Kosuke Ebina, Motomu Hashimoto, Wataru Yamamoto et al. · PLoS ONE · 2018 · 118 citations · Full text

Disease Activity Score, Pharmacotherapy, Inflammatory Arthritis +16

Sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis.

Yasuhiro Yamada, Naoki Yoshimi, Yoshinobu Hirose et al. · PubMed · 2001 · 109 citations

Pathology, Beta-catenin-accumulated Crypts, Tumor Biology +16

Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: a multicentre, prospective, observational study in Japan

Wataru Fukuda, Tadamasa Hanyu, Masaki Katayama et al. · Annals of the Rheumatic Diseases · 2016 · 92 citations · Full text